GE Healthcare and Medtronic have received FDA clearance and European CE mark approval to combine their technology to improve patient monitoring.
Medtronic will integrate its Invos regional technology, which helps track hemodynamic changes and other symptoms of cerebral desaturation, and its Microstream capnography technology, which monitors patients for signs of declining health, into GE Healthcare's Carescape precision monitoring platform, according to a June 1 press release.
GE Healthcare's FlexAcuity technology, designed to help healthcare providers personalize care as needed, is also included in the new offering.
The partnership aims to help connect caregivers and their patients in an ecosystem that supports patient care, enables better decision making and drives efficiencies for healthcare systems.
"Our longstanding collaboration with Medtronic allows GE Healthcare to integrate clinically advanced parameters to enable clinicians with precision monitoring for individualized care," said Neal Sandy, general manager for monitoring solutions at GE Healthcare. "We are able to add these capabilities to both new and existing enterprise monitoring systems, ensuring clinicians have access to real-time, reliable patient insights that can play a critical role in care decisions and outcomes."